SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
of the Securities Exchange Act of 1934
Date of report (Date of earliest event reported): March 27, 2001
INSMED INCORPORATED
(Exact name of registrant as specified in its charter)
VIRGINIA 0-30739 54-1972729
- --------------------------------------------------------------------------------
(State or other jurisdiction of (Commission File Number) (I.R.S. Employer
incorporation) Identification No.)
800 East Leigh Street, Richmond, VA 23219
(Address of principal executive offices and zip code)
Registrant's telephone number, including area code: (804) 828-6893
ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS.
(c) Exhibit.
99.1 Presentation of March 27, 2001.
ITEM 9. REGULATION FD DISCLOSURE.
On March 27, 2001, Insmed Incorporated (the "Company") made a
presentation at the Banc of America Healthcare 2001 Conference.
During the presentation, Dr. Geoffrey Allan, Chairman of the Board,
President and Chief Executive Officer of the Company, indicated
that the slides relating to his prepared remarks would be furnished
for review on the Securities and Exchange Commission's website. The
presentation, which is incorporated herein by reference, is
attached hereto as Exhibit 99.1. Investors may access an archived
audio webcast of the original presentation for 14 days following
the conference at the following URL address:
www.veracast.com/bas_healthcare2001/webcasts/id03105264.cfm
The information in this report (including the exhibit) is furnished
pursuant to Item 9 and shall not be deemed to be "filed" for the
purposes of Section 18 of the Securities Exchange Act of 1934, as
amended, or otherwise subject to the liabilities of that Section.
This report will not be deemed an admission as to the materiality
of any information in the report that is required to be disclosed
solely by Regulation FD.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
INSMED INCORPORATED
Date: March 28, 2001 By: /s/ Michael D. Baer
-----------------------------
Michael D. Baer
Chief Financial Officer
INSMED INCORPORATED
INDEX TO EXHIBITS
Exhibit Number
99.1 Presentation of March 27, 2001.